Press Releases -> Pharmaceuticals & Biotech Syndicate content

Aug 14, 2019

Proceeds to Support Development of Clinical Parkinson’s and Alzheimer’s Candidates and Preclinical Fibrosis Candidate

Financing Led by Octave Life Sciences, joined by Smilegate Investment and other Series A Investors

Aug 02, 2019
  • Channelling Supply Chains of Medical Institutes, High-Tech, Pharma and Medical Devices
  • Getting Ahead for a $2,660 bn Healthcare Sector Booming in Asia Pacific Regions

    TAIPEI --( ASIA TODAY )-- Starting on December 5 through 7 of 2019, The Healthcare+ Expo Taiwan, a powerhouse aligning advanced...

  • Aug 02, 2019

    Rangsit University, a private university in Pathum Thani, Thailand which is one of the few educational institutions licensed by the Thai government to research on the medical use of marijuana and develop respective products, is positive on the development of marihuana as a business case in the country according to...

    Jul 31, 2019

    HYDERABAD, India--(BUSINESS WIRE)--GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a strategic collaboration in...

    Jul 31, 2019

    INCHEON, South Korea, July 31, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy, pending regulatory approvals. UCB's anti-tau candidate is currently...

    Jul 24, 2019

    SINGAPORE, July 24, 2019 - (ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc. ("Global BioLife").

    Jul 23, 2019

    Strategic Healthcare Consulting subsidiary will support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong presence; biopharma and medtech veteran Gary Cheng to lead local team

    Jul 14, 2019

    Kenneth Lee envisions a 'biofarming' future for Hong Kong

    CUHK embryologist Kenneth Lee is working to manufacture living tissue in the lab. That shows great promise for developing human organ patches that could be used to repair the body.

    There’s another important use for manufactured tissue: we can...

    Jul 11, 2019

    SINGAPORE, July 11, 2019 - (ACN Newswire) - Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore (SRIS). With this partnership, the two groups will be working together to promote combined capabilities in...

    Jul 10, 2019

    TOKYO--(BUSINESS WIRE)--Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Morinaga Bifidobacterium longum BB536 has received self-affirmed GRAS (Generally Recognized as Safe) for infant formulas, in honor of its 50th anniversary.

    ...
    Jul 07, 2019

    Strives to Change the Cancer Treatment Model in Hong Kong
    Ready to Tap Tremendous Opportunities in Greater Bay Are

    Jun 17, 2019

    Beijing, 17 June 2019 --( ASIA TODAY )-- Reed Sinopharm Exhibitions (RSE) is delighted to share key highlights from its Personal Care and Homecare Ingredients (PCHi) 2019 post-show report.

    Jun 03, 2019

    FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ -- As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee and the People's...

    Jun 03, 2019

    SEONGNAM-SI, South Korea--(BUSINESS WIRE)--Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial for telacebec (Q203), a first-in-class, orally-available antibiotic for the treatment of tuberculosis (TB). Telacebec is a selective inhibitor with high...

    May 30, 2019

    Promoting precision medicine business with in-house assets and collaboration with external venture partner

    May 28, 2019

    Partnership accelerates access to inebilizumab in China and supports the mission of both companies to bring transformative therapies to more patients around the world

    Viela Bio is eligible to receive an upfront collaboration fee and milestone payments of more than $220 million plus royalties on product sales...

    May 23, 2019

    Singapore, 23 May 2019 --( ASIA TODAY )-- Singapore-based researchers have discovered a possible solution to impede the evolution of bacteria into superbugs that are resistant to drugs and therefore harder to kill. Building on a decade’s work on antimicrobial technologies, the multidisciplinary team from Institute...

    May 21, 2019

    Data Supports Continued Dose Escalation and Further Investigation in Metastatic Renal Cell Carcinoma (mRCC)

    May 16, 2019

    HUDSON, Wis.--(BUSINESS WIRE)--Phillips-Medisize, a Molex company, will have a major exhibiting and speaking presence at the 8th Annual InnoPack Pharma Confex, to be held May 21 – 22 in Mumbai. As an established global leader, Phillips-Medisize provides a wide range of custom drug delivery devices, connected health...

    May 13, 2019

    Himalaya Drug Company to launch new state-of-the-art Global Research Centre in Dubai

    Apr 17, 2019

    HONG KONG, April 17, 2019 /PRNewswire/ -- Cosmoprof Asia, the leading b2b international beauty trade show in Asia, turns 24 this November. The success of the "One Fair, Two Venues" formula is well reflected in the results of the last edition: 5% growth in number of exhibitors to 3,030 companies from 53 countries...

    Apr 10, 2019

    April 10, 2019 08:00 PM Hong Kong Time - AMSTERDAM--(BUSINESS WIRE)--Synaffix B.V., a Dutch biotechnology company exclusively focused on continued advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the development of best-in-class ADCs, announces that it has entered into a license...